Literature DB >> 1849461

Cloning of PI3 kinase-associated p85 utilizing a novel method for expression/cloning of target proteins for receptor tyrosine kinases.

E Y Skolnik1, B Margolis, M Mohammadi, E Lowenstein, R Fischer, A Drepps, A Ullrich, J Schlessinger.   

Abstract

A novel method has been developed to allow cloning of protein targets for receptors with tyrosine kinase activity. By utilizing the carboxy-terminal tail of EGF receptor (EGFR) as a probe to screen lambda gt11 expression libraries, several EGFR-binding proteins have been cloned; two have been analyzed and contain unique SH2 and SH3 domains. One gene (GRB-1) has been fully sequenced, is expressed in various tissues and cell lines, and has a molecular mass of 85 kd. Interestingly, GRB-1 encodes the human counterpart of the PI3 kinase-associated protein p85. Advantages of this technique include the ease of cloning tyrosine kinase receptor targets present at low levels and the ability to identify proteins that are related in their capacity to bind activated receptors but contain no significant DNA sequence homology. This method, termed CORT (for cloning of receptor targets), offers a general approach for the identification and cloning of various receptor targets.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1849461     DOI: 10.1016/0092-8674(91)90410-z

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  174 in total

1.  The N-terminal 34 residues of the 55 kDa regulatory subunits of phosphoinositide 3-kinase interact with tubulin.

Authors:  K Inukai; M Funaki; M Nawano; H Katagiri; T Ogihara; M Anai; Y Onishi; H Sakoda; H Ono; Y Fukushima; M Kikuchi; Y Oka; T Asano
Journal:  Biochem J       Date:  2000-03-01       Impact factor: 3.857

2.  Purification and characterization of a phosphatidylinositol 3-kinase complex from bovine brain by using phosphopeptide affinity columns.

Authors:  M J Fry; G Panayotou; R Dhand; F Ruiz-Larrea; I Gout; O Nguyen; S A Courtneidge; M D Waterfield
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

3.  Activation of Src-like protein-tyrosine kinase Lyn and its association with phosphatidylinositol 3-kinase upon B-cell antigen receptor-mediated signaling.

Authors:  Y Yamanashi; Y Fukui; B Wongsasant; Y Kinoshita; Y Ichimori; K Toyoshima; T Yamamoto
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-01       Impact factor: 11.205

4.  Point mutations in the abl SH2 domain coordinately impair phosphotyrosine binding in vitro and transforming activity in vivo.

Authors:  B J Mayer; P K Jackson; R A Van Etten; D Baltimore
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

5.  Interkinase domain of kit contains the binding site for phosphatidylinositol 3' kinase.

Authors:  S Lev; D Givol; Y Yarden
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

6.  Phage display selection of ligand residues important for Src homology 3 domain binding specificity.

Authors:  R J Rickles; M C Botfield; X M Zhou; P A Henry; J S Brugge; M J Zoller
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

7.  The inability of phosphatidylinositol 3-kinase activation to stimulate GLUT4 translocation indicates additional signaling pathways are required for insulin-stimulated glucose uptake.

Authors:  S J Isakoff; C Taha; E Rose; J Marcusohn; A Klip; E Y Skolnik
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

8.  Association of hematopoietic cell phosphatase with c-Kit after stimulation with c-Kit ligand.

Authors:  T Yi; J N Ihle
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

9.  eps15, a novel tyrosine kinase substrate, exhibits transforming activity.

Authors:  F Fazioli; L Minichiello; B Matoskova; W T Wong; P P Di Fiore
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

10.  The v-Src SH3 domain binds phosphatidylinositol 3'-kinase.

Authors:  X Liu; L E Marengere; C A Koch; T Pawson
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.